Futuximab

Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity.
Read more
€0.00 (tax incl.)
Reference:
HY-P99628
Product Details
HY-P99628

Data sheet

Size
Multiple sizes
Reactivity
EGFR
Application
Cancer-programmed cell death
CAS
1310460-85-5

Menu

Settings